Pan‐cancer analysis identifies CD300 molecules as potential immune regulators and promising therapeutic targets in acute myeloid leukemia

BACKGROUND: CD300s are a group of proteins playing vital roles in immune responses. However, much is yet to be elucidated regarding the expression patterns and clinical significances of CD300s in cancers. METHODS: In this study, we comprehensively investigated CD300s in a pan‐cancer manner using mul...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Zi‐jun, Jin, Ye, Zhang, Xin‐long, Xia, Pei‐hui, Wen, Xiang‐mei, Ma, Ji‐chun, Lin, Jiang, Qian, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9844665/
https://www.ncbi.nlm.nih.gov/pubmed/35642341
http://dx.doi.org/10.1002/cam4.4905

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9844665/
https://www.ncbi.nlm.nih.gov/pubmed/35642341
http://dx.doi.org/10.1002/cam4.4905

Ejemplares similares